ArticleFrontiers in cardiovascular medicine2025
Association between NoSAS score and cardiovascular disease in patients with obstructive sleep apnea.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sleep-Disordered Breathing and Sleep Fragmentation in Relation to Atrial Fibrillation Risk: A Systematic Review and Meta-Analysis.Journal of arrhythmia · 2026Article
- Metabolomic Biomarkers for Non-Invasive Diagnosis of Coronary Artery Disease and Obstructive Sleep Apnea Co-Occurrence.Nature and science of sleep · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Obstructive sleep apnea (OSA) is a common sleep-related respiratory disorder, yet many cases remain undiagnosed. Given the significant association between OSA and various adverse health outcomes, including cardiovascular complications, early identification and intervention are essential. The NoSAS score effectively screens individuals at high risk of OSA, thereby aiding in early detection. Material and methods: Data were collected from the Sleep Medicine Center at the First Affiliated Hospital of Guangzhou Medical University and the Sleep Research Institute at the Second Affiliated Hospital of Guangdong Medical University. Participants with a NoSAS score ≥8 were classified as high-risk, while those with scores <3 were classified as low-risk. Logistic regression was used to analyze the association between high-risk classification and cardiovascular disease morbidity. Result: A total of 2,164 participants with complete NoSAS score data were analyzed. In the high-risk group of 1,248 participants, cardiovascular disease incidence was 7.29%. In the adjusted model, the NoSAS high-risk group demonstrated a 2.2-fold increased risk of cardiovascular disease compared to the low-risk group (OR: 2.22, 95% CI: 1.17-4.18; Conclusion: In conclusion, the NoSAS high-risk group exhibited a higher burden of cardiovascular disease morbidity and served as an independent predictor of this condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.